Phase 3 study of the oral proteasome inhibitor ixazomib for relapsed/refractory AL amyloidosis: TOURMALINE-AL1 by Merlini, G, Dispenzieri, A, Berg, D, Faller, D.V, Hui, A.-M, Comenzo, R.L

Get full text

Meta-Analysis Of The Efficacy And Safety Of Bortezomib (Btz) Retreatment In Patients (Pts) With Multiple Myeloma (Mm) by Knopf, K, Duh, M.S, Lafeuille, M.H, Gravel, J, Lefebvre, P, Niculescu, L, Ba-mancini, A, Ma, E, Shi, H, Comenzo, R.L

Get full text

PCR131 Expanded Diagnoses Outside of Specialized Amyloidosis Centers: Results from the Amyloidosis Research Consortium's 2022 Community Survey by Rebello, S., Hsu, K., Tuchman, S.A., Sperry, B.W., Maurer, M.S., Comenzo, R.L., Mendelson, L., Hassan, H., Lousada, I.

Get full text

siRNA targeting the [kappa] light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases by Ma, X, Zhou, P, Wong, S.W, Warner, M, Chaulagain, C, Comenzo, R.L

Get full text

Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects by Dubrey, S.W., Reece, D.E., Sanchorawala, V., Hegenbart, U., Merlini, G., Palladini, G., Fermand, J.-P., Vescio, R.A., Bladé, J., Heffner, L.T., Hassoun, H., Liu, X., Enny, C., Ramaswami, P., Elsayed, Y., Van De Velde, H., Mortimer, S., Cakana, A., Comenzo, R.L.

Get full text

S875 SUBCUTANEOUS DARATUMUMAB + CYCLOPHOSPHAMIDE, BORTEZOMIB, AND DEXAMETHASONE (CYBORD) IN PATIENTS WITH NEWLY DIAGNOSED AMYLOID LIGHT CHAIN (AL) AMYLOIDOSIS: UPDATED SAFETY RUN‐I... by Comenzo, R.L., Kastritis, E., Maurer, M., Zonder, J., Minnema, M.C., Wechalekar, A., Palladini, G., Qin, X., Vasey, S.Y., Aschan, J., Vermeulen, J., Merlini, G.

Request full text

Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolid... by Landau, H.J, Hassoun, H, Rosenzweig, M.A, Bello, C, Hoover, E, Riedel, E, Comenzo, R.L

Get full text

Urinary Excretion of Epinephrine and Dopamine Correlates with Efficiency of G-CSF Mobilized Stem Cells in Patients with Al Amyloidosis by Landau, H.J, Bello, C, Hoover, E, Riedel, E, Frenette, P, Comenzo, R.L

Get full text

PCN12 - Meta-Analysis Of The Efficacy And Safety Of Bortezomib (Btz) Retreatment In Patients (Pts) With Multiple Myeloma (Mm) by Knopf, K., Duh, M.S., Lafeuille, M.H., Gravel, J., Lefebvre, P., Niculescu, L., Ba-mancini, A., Ma, E., Shi, H., Comenzo, R.L.

Get full text

Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic κ1 light chain by Wally, J., Kica, G., Zhang, Y., Ericsson, T., Connors, L.H., Benson, M.D., Liepnieks, J.J., Murray, J., Skinner, M., Comenzo, R.L.

Get full text

Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic κ 1 light chain by Wally, J., Kica, G., Zhang, Y., Ericsson, T., Connors, L.H., Benson, M.D., Liepnieks, J.J., Murray, J., Skinner, M., Comenzo, R.L.

Get full text

Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic al... by Cohen, A.D., Zhou, P., Reich, L., Fircanis, S., Drake, L., Hedvat, C., Teruya-Feldstein, J., Filippa, D.A., Fleisher, M., Comenzo, R.L.

Get full text